Mirimus
Latest round
- Series A
Last raised
- Mar 2011
Total raised
- $2M
Investors
- 2
About Mirimus
Mirimus, Inc.Founded in 2010 and headquartered in Brooklyn, US, Mirimus, Inc. specializes in preclinical evaluation using custom RNA interference (RNAi) and CRISPR/Cas9 models.Mirimus specializes in innovative biotech solutions, focusing on preclinical evaluation through advanced genetically engineered in vivo models. The company's core offerings include custom RNA interference (RNAi) and CRISPR/Cas9 mouse and rat models for precise gene silencing in drug discovery. Furthermore, Mirimus develops 3D tissue cultures from induced pluripotent stem cells (iPSCs), emulating human organ architecture and physiology.Mirimus generates revenue mainly through B2B transactions with pharmaceutical and biotech companies, academic institutions, and research organizations. The company offers structured partnerships and custom contracts tailored to specific research needs, including animal models and tissue cultures. Revenue is derived from service agreements reflecting the complexity and duration of projects, ensuring that products meet client specifications.Mirimus aims to develop new products, including enhanced models and advanced tissue cultures, although specific release dates are not disclosed. The company is also looking to expand into European and Asian markets by 2015.
Who invested in Mirimus
2 investors across 1 round
See all investors in Mirimus
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Mar 2, 2011
Amount
$2M
Investors
Questions about Mirimus
Who invested in Mirimus?
Mirimus has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mirimus raised?
Mirimus has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mirimus last raise money?
Mirimus's most recent round on record is a Series A, in Mar 2011.
What does Mirimus do?
Mirimus is a biotechnology company.
Where is Mirimus headquartered?
Mirimus is headquartered in Brooklyn, US.
Which VCs invest in companies like Mirimus?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mirimus's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mirimus? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.